Physician profile
Christopher Crane
NPI 1306098793
$1,250.75
in general payments reported to CMS, 2019-2025
10 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $15.31 · 2021: $32.00 · 2022: $61.34 · 2023: $5.99 · 2024: $668 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $580 · Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $580.18 |
| Food and Beverage | $262.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $558.00 | 2024 | Opalescence |
| Align Technology, INC. | $168.56 | 2019-2024 | Invisalign, Vivera Retainers |
| World Class Technology Corporation | $147.55 | 2019 | |
| 3m Company | $125.90 | 2019-2022 | |
| Gc America INC. | $84.46 | 2025 | Spring, Experience, Bio-Active |
| Ortho Organizers, INC. | $60.07 | 2019-2022 | |
| Solventum Corporation | $45.71 | 2025 | Clarity Aligners |
| Straumann USA LLC | $23.06 | 2025 | |
| American Orthodontics Corporation | $22.18 | 2024 | Master Series, Radiance, Empower-Ceramic |
| Envista Holdings Corporation | $15.26 | 2025 | Bluegloo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Crane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.